{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T11:30:56Z","timestamp":1784719856501,"version":"3.55.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["KFJ-STS-QYZD-2021-12-001"],"award-info":[{"award-number":["KFJ-STS-QYZD-2021-12-001"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007865","name":"University of Texas Medical Branch","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.isci.2024.110972","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T18:38:38Z","timestamp":1726598318000},"page":"110972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A safer cell-based yellow fever live attenuated vaccine protects mice against YFV infection"],"prefix":"10.1016","volume":"27","author":[{"given":"Weiwei","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhong","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuekai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaoling","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2024.110972_bib1","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41564-020-0714-0","article-title":"The continued threat of emerging flaviviruses","volume":"5","author":"Pierson","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.isci.2024.110972_bib2","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.4023707","article-title":"Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution","volume":"229","author":"Rice","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.isci.2024.110972_bib3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jcv.2014.08.030","article-title":"Yellow fever","volume":"64","author":"Monath","year":"2015","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.isci.2024.110972_bib4","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.3390\/ijms22073738","article-title":"Information Encoded by the Flavivirus Genomes beyond the Nucleotide Sequence","volume":"22","author":"Ramos-Lorente","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2024.110972_bib5","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1093\/infdis\/jiz375","article-title":"Global Risk and Elimination of Yellow Fever Epidemics","volume":"221","author":"Ndeffo-Mbah","year":"2020","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.isci.2024.110972_bib6","article-title":"Yellow Fever: Origin, Epidemiology, Preventive Strategies and Future Prospects","volume":"10","author":"Gianchecchi","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.isci.2024.110972_bib7","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.64670","article-title":"The global burden of yellow fever","volume":"10","author":"Gaythorpe","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.isci.2024.110972_bib8","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1089\/vbz.2016.2031","article-title":"Yellow Fever Remains a Potential Threat to Public Health","volume":"16","author":"Vasconcelos","year":"2016","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.isci.2024.110972_bib9","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.mehy.2006.01.060","article-title":"Midzonal lesions in yellow fever: a specific pattern of liver injury caused by direct virus action and in situ inflammatory response","volume":"67","author":"Quaresma","year":"2006","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.isci.2024.110972_bib10","first-page":"77","article-title":"The yellow fever vaccine: a history","volume":"83","author":"Frierson","year":"2010","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.isci.2024.110972_bib11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1084\/jem.65.6.787","article-title":"The Use of Yellow Fever Virus Modified By In\u00a0Vitro Cultivation For Human Immunization","volume":"65","author":"Theiler","year":"1937","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.isci.2024.110972_bib12","first-page":"895","article-title":"Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine","volume":"59","author":"Poland","year":"1981","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.isci.2024.110972_bib13","doi-asserted-by":"crossref","first-page":"398","DOI":"10.12688\/f1000research.11280.1","article-title":"Yellow fever in the Americas: the growing concern about new epidemics","volume":"6","author":"Ortiz-Mart\u00ednez","year":"2017","journal-title":"F1000Res."},{"key":"10.1016\/j.isci.2024.110972_bib14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40409-018-0162-y","article-title":"Yellow fever in Africa and the Americas: a historical and epidemiological perspective","volume":"24","author":"Chippaux","year":"2018","journal-title":"J.\u00a0Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.isci.2024.110972_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/v13081475","article-title":"Yellow Fever Outbreak in Eastern Senegal, 2020-2021","volume":"13","author":"Diagne","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2024.110972_bib16","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.coi.2009.05.018","article-title":"Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?","volume":"21","author":"Barrett","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.isci.2024.110972_bib17","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/14760584.2016.1180250","article-title":"Yellow fever vaccine: worthy friend or stealthy foe?","volume":"15","author":"Seligman","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.isci.2024.110972_bib18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/14760584.4.4.553","article-title":"Yellow fever vaccine","volume":"4","author":"Monath","year":"2005","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.isci.2024.110972_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ph14090891","article-title":"The Present and Future of Yellow Fever Vaccines","volume":"14","author":"Hansen","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.isci.2024.110972_bib20","article-title":"Disease Resurgence, Production Capability Issues and Safety Concerns in the Context of an Aging Population: Is There a Need for a New Yellow Fever Vaccine?","volume":"7","author":"Tomashek","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.isci.2024.110972_bib21","first-page":"193","article-title":"Eliminate Yellow fever Epidemics (EYE): a global strategy, 2017\u20132026","volume":"92","year":"2017","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.isci.2024.110972_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1056\/NEJMp1606997","article-title":"Yellow Fever in Angola and Beyond--The Problem of Vaccine Supply and Demand","volume":"375","author":"Barrett","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2024.110972_bib23","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1016\/S0140-6736(16)31838-4","article-title":"Fractional dosing of yellow fever vaccine to extend supply: a modelling study","volume":"388","author":"Wu","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2024.110972_bib24","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0140-6736(01)07185-9","article-title":"Shortage of vaccines during a yellow fever outbreak in Guinea","volume":"358","author":"Nathan","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2024.110972_bib25","first-page":"tax008","article-title":"Importation of yellow fever into China: assessing travel patterns","volume":"24","author":"Wilder-Smith","year":"2017","journal-title":"J.\u00a0Travel Med."},{"key":"10.1016\/j.isci.2024.110972_bib26","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1128\/JVI.77.3.2265-2270.2003","article-title":"Fine mapping of a cis-acting sequence element in yellow fever virus RNA that is required for RNA replication and cyclization","volume":"77","author":"Corver","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2024.110972_bib27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.virol.2005.06.009","article-title":"Role of RNA structures present at the 3'UTR of dengue virus on translation, RNA synthesis, and viral replication","volume":"339","author":"Alvarez","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.isci.2024.110972_bib28","doi-asserted-by":"crossref","first-page":"22521","DOI":"10.1074\/jbc.M111.234302","article-title":"Identification of cis-acting elements in the 3'-untranslated region of the dengue virus type 2 RNA that modulate translation and replication","volume":"286","author":"Manzano","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2024.110972_bib29","doi-asserted-by":"crossref","first-page":"9652","DOI":"10.1128\/JVI.78.18.9652-9665.2004","article-title":"Genetic relationships and evolution of genotypes of yellow fever virus and other members of the yellow fever virus group within the Flavivirus genus based on the 3' noncoding region","volume":"78","author":"Mutebi","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2024.110972_bib30","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.tim.2016.01.002","article-title":"RNA Structure Duplications and Flavivirus Host Adaptation","volume":"24","author":"Villordo","year":"2016","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.isci.2024.110972_bib31","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1099\/vir.0.82235-0","article-title":"Direct repeats in the 3' untranslated regions of mosquito-borne flaviviruses: possible implications for virus transmission","volume":"87","author":"Gritsun","year":"2006","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.isci.2024.110972_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.aab3369","article-title":"Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness","volume":"350","author":"Manokaran","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.isci.2024.110972_bib33","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1128\/JVI.77.2.1653-1657.2003","article-title":"A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3' untranslated region is highly attenuated and immunogenic in monkeys","volume":"77","author":"Whitehead","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2024.110972_bib34","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.chom.2008.10.007","article-title":"A Highly Structured, Nuclease-Resistant, Noncoding RNA Produced by Flaviviruses Is Required for Pathogenicity","volume":"4","author":"Pijlman","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.isci.2024.110972_bib35","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1099\/0022-1317-78-7-1543","article-title":"Secondary structure of the 3'-untranslated region of yellow fever virus: implications for virulence, attenuation and vaccine development","volume":"78","author":"Proutski","year":"1997","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.isci.2024.110972_bib36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0168-1702(99)00079-9","article-title":"Biological consequences of deletions within the 3'-untranslated region\u00a0of flaviviruses may be due to rearrangements of RNA secondary structure","volume":"64","author":"Proutski","year":"1999","journal-title":"Virus Res."},{"key":"10.1016\/j.isci.2024.110972_bib37","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/nar\/25.6.1194","article-title":"Secondary structure of the 3' untranslated region of flaviviruses: similarities and differences","volume":"25","author":"Proutski","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2024.110972_bib38","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1128\/JVI.79.6.3807-3821.2005","article-title":"Size heterogeneity in the 3' noncoding region of South American isolates of yellow fever virus","volume":"79","author":"Bryant","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2024.110972_bib39","doi-asserted-by":"crossref","first-page":"11407","DOI":"10.1128\/JVI.01159-10","article-title":"RNA structures required for production of subgenomic flavivirus RNA","volume":"84","author":"Funk","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2024.110972_bib40","doi-asserted-by":"crossref","first-page":"7122","DOI":"10.1093\/nar\/gkab462","article-title":"Three-dimensional structure of a flavivirus dumbbell RNA reveals molecular details of an RNA regulator of replication","volume":"49","author":"Akiyama","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2024.110972_bib41","doi-asserted-by":"crossref","first-page":"11395","DOI":"10.1128\/JVI.01047-10","article-title":"An RNA pseudoknot is required for production of yellow fever virus subgenomic RNA by the host nuclease XRN1","volume":"84","author":"Silva","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2024.110972_bib42","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1099\/vir.0.18860-0","article-title":"A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication","volume":"84","author":"Bredenbeek","year":"2003","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.isci.2024.110972_bib43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.2001.65.405","article-title":"Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region","volume":"65","author":"Durbin","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.isci.2024.110972_bib44","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2046960","article-title":"A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-na\u00efve and flavivirus-experienced healthy adults","volume":"18","author":"Russell","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.isci.2024.110972_bib45","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nm.4322","article-title":"A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models","volume":"23","author":"Shan","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2024.110972_bib46","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114108","article-title":"Rational design of West Nile virus vaccine through large replacement of 3' UTR with internal poly(A)","volume":"13","author":"Zhang","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.isci.2024.110972_bib47","doi-asserted-by":"crossref","first-page":"10004","DOI":"10.1128\/JVI.77.18.10004-10014.2003","article-title":"Functional analysis of mosquito-borne flavivirus conserved sequence elements within 3' untranslated region of West Nile virus by use of a reporting replicon that differentiates between viral translation and RNA replication","volume":"77","author":"Lo","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2024.110972_bib48","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2021.1895644","article-title":"Re-thinking yellow fever vaccines: fighting old foes with new generation vaccines","volume":"18","author":"Montalvo Zurbia-Flores","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.isci.2024.110972_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000614","article-title":"A mouse model for studying viscerotropic disease caused by yellow fever virus infection","volume":"5","author":"Meier","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2024.110972_bib50","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.vaccine.2021.02.033","article-title":"Next generation live-attenuated yellow fever vaccine candidate: Safety and immuno-efficacy in small animal models","volume":"39","author":"Piras-Douce","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2024.110972_bib51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41541-023-00629-7","article-title":"Immunogenicity and protective activity of mRNA vaccine candidates against yellow fever virus in animal models","volume":"8","author":"Medina-Mag\u00fces","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.isci.2024.110972_bib52","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1016\/j.vaccine.2012.03.003","article-title":"A small animal peripheral challenge model of yellow fever using interferon-receptor deficient mice and the 17D-204 vaccine strain","volume":"30","author":"Thibodeaux","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2024.110972_bib53","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.tim.2018.05.012","article-title":"Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe","volume":"26","author":"Douam","year":"2018","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.isci.2024.110972_bib54","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.virol.2008.04.043","article-title":"Comprehensive analysis of T\u00a0cell epitope discovery strategies using 17DD yellow fever virus structural proteins and BALB\/c (H2d) mice model","volume":"378","author":"Maciel","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.isci.2024.110972_bib55","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1084\/jem.20082292","article-title":"Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses","volume":"205","author":"Gaucher","year":"2008","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.isci.2024.110972_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104596","article-title":"Genetic stability of live-attenuated Zika vaccine candidates","volume":"171","author":"Muruato","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.isci.2024.110972_bib57","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11908-017-0566-9","article-title":"Live Attenuated Yellow Fever 17D Vaccine: A Legacy Vaccine Still Controlling Outbreaks In Modern Day","volume":"19","author":"Collins","year":"2017","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.isci.2024.110972_bib58","doi-asserted-by":"crossref","DOI":"10.26633\/RPSP.2018.75","article-title":"Yellow fever vaccine and risk of developing serious adverse events: a systematic review","volume":"42","author":"Porudominsky","year":"2018","journal-title":"Rev. Panam. Salud. Publica."},{"key":"10.1016\/j.isci.2024.110972_bib59","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1009303","article-title":"An inactivated cell-culture vaccine against yellow fever","volume":"364","author":"Monath","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2024.110972_bib60","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.3389\/fimmu.2018.01756","article-title":"Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model","volume":"9","author":"Julander","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2024.110972_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.757084","article-title":"Biological Characterization of Yellow Fever Viruses Isolated From Non-human Primates in Brazil With Distinct Genomic Landscapes","volume":"13","author":"Furtado","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2024.110972_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/0022-1317-46-1-1","article-title":"The in\u00a0vivo differentiation of strains of yellow fever virus in mice","volume":"46","author":"Fitzgeorge","year":"1980","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.isci.2024.110972_bib63","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1016\/j.vaccine.2010.03.023","article-title":"Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activity","volume":"28","author":"Monath","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2024.110972_bib64","article-title":"Development of a Bicistronic Yellow Fever Live Attenuated Vaccine with Reduced Neurovirulence and Viscerotropism","volume":"10","author":"Wang","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.isci.2024.110972_bib65","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1128\/JVI.76.12.5847-5856.2002","article-title":"Infectious cDNA clone of the epidemic west nile virus from New York City","volume":"76","author":"Shi","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2024.110972_bib66","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.chom.2016.05.004","article-title":"An Infectious cDNA Clone of Zika Virus to Study Viral Virulence, Mosquito Transmission, and Antiviral Inhibitors","volume":"19","author":"Shan","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.isci.2024.110972_bib67","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-981-10-8727-1_12","article-title":"Establishment and Application of Flavivirus Replicons","volume":"1062","author":"K\u00fcmmerer","year":"2018","journal-title":"Adv. Exp. Med. Biol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224021977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224021977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T01:02:04Z","timestamp":1783386124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004224021977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":67,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2589004224021977"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2024.110972","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A safer cell-based yellow fever live attenuated vaccine protects mice against YFV infection","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2024.110972","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110972"}}